We examined the effects of the top five drugs per AD stage (13 drugs in total) derived from our previous computational drug repurposing work [13], against the enzymatic activity of the BACE1 enzyme, using a commercial inhibitor screening assay. Here, BACE1 is linked to Alzheimer disease.